Originally developed by Eli Lilly under the research code LY3437943 , retatrutide remains an investigational compound currently progressing through large Phase 3 clinical trials
Thousands of people on semaglutide want to know exactly what their blood work will show, what it will not show, and whether their healthcare provider can spot the medication without being told
Medical Disclaimer: This article is intended for informational purposes only and should not be taken as medical advice
Bedtime within a 60-minute window, dark room, no late screens, no alcohol close to bed
Abbreviations RGCs: retinal ganglion cells GFAP: glial fibrillary acidic protein NOS: nitric oxide synthase NO: nitric oxide iNOS: inducible NOS MTC: methylcellulose Ub: ubiquitin MDA: malondialdehyde IOP: intraocular pressure References Cedrone C, Mancino R, Cerulli A, Cesareo M, Nucci C
23 , 621631.e627 (2025)